Medtech Insight is part of the Informa Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Roche takes HPV (human papillomavirus) PCR reagent to the US:

This article was originally published in Clinica

Executive Summary

Roche has released in the US its PCR-based reagent for detecting human papillomavirus (HPV), the leading cause of cervical cancer. The Amplicor HPV system is the first PCR-based reagent for the virus and may be used to develop a "home brew" assay in US laboratories. The product identifies all 13 high-risk genotypes of HPV. Roche also expects to launch a CE-marked kit in Europe within the next few months.

Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register

MT057199

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel